Charge and size selectivity of proteinuria in children with idiopathic nephrotic syndrome

Taylor, G. Michael; Neuhaus, Thomas J.; Shah, Vanita; Dillon, Susannah; Barratt, T. Martin
July 1997
Pediatric Nephrology;1997, Vol. 11 Issue 4, p404
Academic Journal
Experimental studies have pointed to charge selectivity as an important determinant of glomerular permeability to macromolecules. Loss of glomerular basement membrane (GBM) polyanion has been proposed as a cause of the selective proteinuria in minimal change nephrotic syndrome (MCNS). However, the presence of less-anionic albumin in urine than plasma from MCNS and focal and segmental glomerulosclerosis (FSGS) patients has been interpreted both as evidence for partial maintenance of charge selectivity and for involvement of other pathogenic mechanisms. The exact role of charge selectivity in the pathogenesis of nephrotic proteinuria remains controversial. We have examined the clearance of endogenous proteins of differing size and charge in children with idiopathic nephrotic syndrome (NS). Chromatofocusing was used to determine the isoelectric points (pIs) of albumins in paired plasma and urine samples from patients with FSGS (n = 6) and MCNS (n = 6). Charge selectivity was assessed by comparing the pls of the fractions with the highest albumin concentration (modal pI) in plasma and urine. The difference between the modal pIs was defined as the delta modal pI. Charge selectivity was also assessed from the albumin/transferrin and IgG4/IgG1 clearance ratios; size selectivity from the IgG1/albumin and IgG1/transferrin as well as the IgG4/albumin and IgG4/transferrin clearances. In children with FSGS, the mean (± SD) delta modal pI was -0.05 ± 0.16, and in MCNS-0.05 ± 0.11. Neither value differed significantly from zero. The albumin/transferrin clearance ratio showed no significant difference between FSGS and MCNS, but the IgG4/IgG1 clearance ratio was significantly higher in MCNS (P<0.05). Size selectivity was significantly reduced in FSGS compared with MCNS (for IgG1/transferrin P < 0.01 and for IgG1/albumin P<0.05). For IgG4/transferrin and IgG4/albumin, P was <0.05. In conclusion, there was no evidence for residual charge selectivity in...


Related Articles

  • Recognizing and treating the nephrotic syndrome: Avoid unnecessary delays. Hogg, Ronald J.; Portman, Ronald J.; Milliner, Dawn; Lemley, Kevin V.; Eddy, Allison; Ingelfinger, Julie // Contemporary Pediatrics;Nov2000, Vol. 17 Issue 11, p84 

    Offers recommendations for evaluating and treating proteinuria and nephrotic syndrome (NS). Normal daily rate of protein excretion in the urine; First step in evaluating a child with persistent dipstick proteinuria; Clinical features of childhood NS.

  • Age and ethnicity affect the risk and outcome of focal segmental glomerulosclerosis. Sorof, Jonathan M.; Hawkins, Edith P.; Brewer, Eileen D.; Boydstun, Ivy I.; Kale, Arundhati S.; Powell, David R. // Pediatric Nephrology;1998, Vol. 12 Issue 9, p764 

    In patients with proteinuria, African-American (AA) ethnicity is reported to be a risk factor for focal segmental glomerulosclereosis (FSGS) and its progression to end-stage renal disease (ESRD). We reviewed our single-center experience to determine the probability of FSGS and its progression to...

  • Pulse methylprednisolone treatment of idiopathic steroid-resistant nephrotic syndrome. Yorgin, P. D.; Krasher, Judy; Al-Uzri, Amira Y. // Pediatric Nephrology;2001, Vol. 16 Issue 3, p245 

    Although much of the interest in pulse methylprednisolone therapy (PMT) has centered around its use in children with focal segmental glomerulosclerosis, PMT has also been shown to be effective in the treatment of other proteinuric renal diseases. We hypothesized that a PMT-based treatment...

  • Enalapril and prednisone in children with nephrotic-range proteinuria. Delucchi, A.; Cano, F.; Rodriguez, E.; Wolff, E.; Gonzalez, X.; Cumsille, M. A. // Pediatric Nephrology;Oct2000, Vol. 14 Issue 12, p1088 

    The effect of enalapril and low prednisone doses on the urinary protein electrophoretic pattern was studied in 13 pediatric patients with glomerular diseases and steroid-resistant nephrotic syndrome. Enalapril was administred at doses of 0.2–0.6 mg/kg per day for 24–84 months, and...

  • Nephrotic syndrome at 5 months: no definitive treatment or complications for 12 years. Garza, Mary B.; Guttenberg, Marta; Kaplan, B. S. // Pediatric Nephrology;1999, Vol. 13 Issue 7, p604 

    We describe a patient who developed nephrotic syndrome at 5 months, with extensive glomerular and tubular damage on biopsy. The patient was treated with diuretics and was asymptomatic for a decade despite unremitting proteinuria. A repeat biopsy at 13 years of age showed remarkable healing with...

  • Literature Abstract. Lama, G.; Luongo, I.; Piscitelli, A.; Salsano, M.E. // Pediatric Nephrology;Sep2001, Vol. 16 Issue 9, p712 

    Focuses on the antiproteinuric effect of angiotensin converting enzyme-I or enalapril in children with nephrotic syndrome. Increase of albumin levels after the treatment; Stability of creatinine clearance; Reduction of proteinuria.

  • Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains. Tessa J. M. Wijnhoven; Joyce M. Geelen; Marinka Bakker; Joost F. M. Lensen; Angelique L. W. M. M. Rops; Andrea B. Kramer; Gerjan Navis; Mabel J. W. van den Hoven; Johan van der Vlag; Jo H. M. Berden; Jack F. M. Wetzels; Lambert P. W. J. van den Heuvel; Leo A. H. Monnens; Toin H. van Kuppevelt // Nephrology Dialysis Transplantation;Oct2007, Vol. 22 Issue 10, p2886 

    Background. Minimal change nephrotic syndrome (MCNS) is the most frequent form of nephrotic syndrome in childhood. In the glomerular basement membrane (GBM) of adult patients with MCNS, a reduced expression of a specific heparan sulphate (HS) domain has been reported. In children with MCNS,...

  • Prednisolone.  // Reactions Weekly;11/2/2013, Issue 1476, p29 

    The article presents a case study of a 10-year-old girl who developed proteinuria after taking prednisolone for nephrotic syndrome.

  • Urine proteomic profiling of pediatric nephrotic syndrome. Khurana, Mona; Traum, Avram; Aivado, Manuel; Wells, Meghan; Guerrero, Manuel; Grall, Franck; Libermann, Towia; Schachter, Asher // Pediatric Nephrology;Sep2006, Vol. 21 Issue 9, p1257 

    The prognosis of pediatric nephrotic syndrome (NS) correlates with the responsiveness to glucocorticoid therapy. Steroid-resistant NS (SRNS) patients progress to end-stage renal disease, while steroid-sensitive NS (SSNS) and steroid-dependent (SDNS) patients do not. We have performed proteomic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics